Objective: Mechanical aortic valve replacement (AVR) is still the recommended valve substitute in young adults, although cultural reasons have popularized bioprostheses also in these patients. Indeed, structural valve deterioration (SVD) is still the major concern of bioprosthesis in young adults. ...
(5)INSPIRIS RESILIA瓣膜¹应用VFit可扩展瓣架技术(适用于19mm-25mm尺寸),为瓣中瓣疗法预留了解决方案,倘若该67岁患者若干年以后瓣膜衰败,可以给予瓣中瓣TAVR治疗。 在手术操作体验方面,第一,我认为INSPIRIS RESILIA主动脉瓣¹能简化术...
[1] INSPIRIS RESILIA:主动脉瓣膜,适用于天然或人工主动脉心脏瓣膜的置换,注册证编号:国械注进20203130521。 [2] Griffith, et al. Four-year Outcomes of Aortic Valve Replacement with a Bioprosthetic Valve with a Novel Tissue. Ameri...
[1]Bartus K, Litwinowicz R, Bilewska A, Stapor M, Bochenek M, Rozanski J, Sadowski J, Filip G, Kusmierczyk M, Kapelak B. Final 5-year outcomes following aortic valve replacement with a RESILIA™ tissue bioprosthesis. Eur J Cardiothorac Surg. 2020 Nov 3:ezaa311. [2]Griffith, et ...
[1] INSPIRIS RESILIA:主动脉瓣膜,适用于天然或人工主动脉心脏瓣膜的置换,注册证编号:国械注进20203130521 [2] Bavaria J E , Griffith B , Heimansohn D A , et al. Five-year Outcomes of the COMMENCE Trial Investigating Aortic Valve Replacement with RESILIA Tissue. 2022. ...
干式主动脉瓣膜EDWARDS INSPIRIS RESILIA Aortic Valve,该产品由瓣叶,瓣架,瓣座和缝合环构成。瓣叶材料为经处理的牛心包组织,瓣膜的支架由外包聚酯布的Elgiloy合金构成,缝合环由外包聚四氟乙烯布的硅橡胶构成。环氧乙烷灭菌,干式密封保存,一次性使用,货架有效期四年
Preliminary Experience with Edwards INSPIRIS RESILIA Compared with Carpentier-Edwards PERIMOUNT MAGNA EASE for Aortic Valve Replacement: A Propensity-score Matched Pilot StudyMethods: All adult patients undergoing aortic valve replacement in the last 12 months were enrolled (182 patients receiving PM-EASE,...
Preliminary Experience with Edwards INSPIRIS RESILIA® Compared with Carpentier-Edwards PERIMOUNT MAGNA EASE® for Aortic Valve Replacement: A Propensity-score Matched Pilot StudyIlaria FranzeseAlessandra FrancicaIlaria TropeaFilippo TonelliLivio San Biagio...
Incorporating the 4th generation Inspiris Resilia valve into the Valsalva graft does not complicate the procedure. Aortic root aneurysm patients show excellent early and mid-term outcomes, with a 90.2卤5.5% survival rate at 4-year. Longer follow-up is needed to evaluate long-term outcomes.A. ...
the increasing use of biological prostheses for surgical aortic valve replacement (AVR), has led to the development of new devices with improved hemodynamics and expected durability.#In this observational retrospective two-center cohort study, two innovative bioprostheses, INSPIRIS Resilia and AVALUS wer...